Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival

Radiology

Volumn 243, Issue 3, 2007, Pages 744-751

  Wieder, Hinrich A ^a   Rosenberg, Robert ^a   Lordick, Florian ^a   Geinitz, Hans ^a   Beer, Ambros ^a   Becker, Karen ^a   Woertler, Klaus ^a   Dobritz, Martin ^a   Siewert, Jörg R ^a   Rummeny, Ernst J ^a   Stollfuss, Jens C ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GADOLINIUM PENTETATE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOLOGIST; RECTUM BIOPSY; RECTUM CANCER; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME; TUMOR RECURRENCE; UNIVARIATE ANALYSIS;

CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 34249077965     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2433060421     Document Type: Article

References (37)

1. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309-320.
2. Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994;23:498-505.
3. Jass JR, Love SB. Prognostic value of direct spread in Dukes' C cases of rectal cancer. Dis Colon Rectum 1989;32:477-480.
4. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes' C class of colorectal cancer: an analysis of the NSABP clinical trials. Ann Surg 1986;203:115-122.
5. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 1995;48:849-855.
6. Cawthorn SJ, Parums DV, Gibbs NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055-1059.
7. Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42:167-173.
8. Barrett MW. Chemoradiation for rectal cancer: current methods. Semin Surg Oncol 1998;13:114-119.
9. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
10. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
11. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004;232:335-346.
12. Hall NR, Finan PJ, al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: predictor of survival but not local recurrence? Dis Colon Rectum 1998;41:979-983.
13. Marijnen CA, Nagtegaal ID, Kapiteijn E, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;55: 1311-1320.
14. Luna-Perez P, Bustos-Cholico H, Alvarado I, et al. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2003;90:20-25.
15. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357: 497-504.
16. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;90:355-364.
17. Martling A, Holm T, Bremmer S, Lindholm J, Cedermark B, Blomqvist L. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer. Br J Surg 2003;90:1422-1428.
18. Brown G, Kirkham A, Williams GT, et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004;182:431-439.
19. Wood DA. Clinical staging and end results classification: TNM system of clinical classification as applicable to carcinoma of the colon and rectum. Cancer 1971;28:109-114.
20. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994;73:2680-2686.
21. Radcliffe A, Brown G. Will MRI provide maps of lines of excision for rectal cancer? [editorial]. Lancet 2001;357:495-496.
22. Nelson II, Sargent DJ. Refining multimodal therapy for rectal cancer [editorial]. N Engl J Med 2001;345:690-692.
23. Pahlman L. Neoadjuvant and adjuvant radio-and radio-chemotherapy of rectal carcinomas. Int J Colorectal Dis 2000;15:1-8.
24. Wibe A, Rendedal PR, Svensson K, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89: 327-334.
25. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2: 996-999.
26. Ng CS, Husband JF, MacVicar AD, Ross P, Cunningham DC. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol 1998;53:422-427.
27. Grabbe F, Lierse W, Winkler R. The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology 1983;149: 241-246.
28. Blomqvist L, Rubio C, Holm T, Machado M, Hindmarsh T. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol 1999;72:18-23.
29. Vliegen RF, Beets GL, von Meyenfeldt MF, et al. Rectal career: MR imaging in local staging - is gadolinium-based contrast material helpful? Radiology 2005;234:179-188.
30. Beets-Tan RG, Beets GL. Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorectal Dis 2003;18:385-391.
31. Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 1997;40: 515-522.
32. Stryker SJ, Kiel KD, Rademaker A, Shaw JM, Ujiki GT, Poticha SM. Preoperative "chemoradiation" for stages II and III rectal carcinoma. Arch Surg 1996;131:514-518.
33. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-1029.
34. Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-786; discussion 786-787.
35. Beets-Tan RG, Lettinga T, Beets GL. Preoperative imaging of rectal cancer and its impact on surgical performance and treatment outcome. Eur J Surg Oncol 2005;31: 681-688.
36. Bosset JF, Mantion G, Lorchel F, et al. Adjuvant and neoadjuvant radiation therapy for rectal cancer. Semin Oncol 2000;27:60-65.
37. Bosset JF, Magnin V, Maingon P, et al. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int J Radiat Oncol Biol Phys 2000;46:323-327.